Paolo Daniele Siviero

Director of  Principia III Health fund, a specialized venture capital fund targeting biotech and medical technology companies. Principia III, the third venture capital fund set up by Principia SGR, become the largest Italian strategic investor in a sector widely expected to be the major driver in knowledge-based economies after the information technology revolution.

Paolo Siviero worked for the Italian Medicines Agency (AIFA) from 2007 to 2014 where he led the “Economic Strategy and Pharmaceutical Policy” Unit, responsible for the sustainability of the National Health System with respect to the pharmaceutical sector. During this time, Mr. Siviero was also appointed as:

During his career Mr. Siviero has cooperated several years with the Italian National Research Council, regarding the development of issues such as the technological transfer, knowledge management and the economical valorization of results obtained through researches.